We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Selltech?

1 December 2003 By Robert Cyran

Pfizer has dropped its right to sell Celltech’s arthritis drug. With a majority of Celltech s value tied up in this one drug and new drugs hard to find the company may find suitors knocking.

This content is for Subscribers only

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)